Dynavox Group (DYVOX) Q2 2025 earnings summary

Executive summary

• Revenue grew 38% year-over-year in Q2 2025 (currency-adjusted), with organic growth at 37% and strong momentum across all markets and user segments, especially among younger users with autism.

• EBIT was SEK 44 million, impacted by SEK 51 million in non-recurring costs, reflecting strong underlying profitability above long-term targets.

• Strategic acquisitions in France (Cenomy completed) and Germany (RehaMedia signed) expand direct market presence and team.

• Investments in ERP and organizational consolidation are progressing as planned, with SEK 50 million spent year-to-date and a total of SEK 100 million expected for 2025.

• Cash flow after investments was negative SEK 100 million, mainly due to acquisitions and infrastructure investments.

Financial highlights

• Q2 2025 revenue: SEK 603 million, up 38% year-over-year (currency-adjusted); organic growth 37%.

• Gross margin: 67%, down 1.2 percentage points due to currency and freight costs.

• EBIT: SEK 44 million; EBIT margin: 7.4%, temporarily reduced by SEK 51 million in non-recurring costs.

• EPS: SEK 0.27, down from SEK 0.34 last year.

• Net debt: SEK 851 million; cash at hand: SEK 157 million at quarter end.

Outlook and guidance

• No signs of market saturation; growth in all geographies and user segments expected to continue.

• 2025 investments in ERP and R&D restructuring to total SEK 100 million, with cost run-rate normalizing in 2026.

• Financial targets: 20% annual revenue growth (currency-adjusted, including acquisitions) and EBIT margin at or above 15% over 3–4 years.

• Dividend policy: at least 40% of available net profits to be distributed via dividends or buybacks, subject to growth priorities.

• Continued focus on profitable growth through acquisitions and investments in scalability.